Search

Michael A Statnick

from Salt Lake City, UT
Age ~58

Michael Statnick Phones & Addresses

  • 108 U St, Salt Lake Cty, UT 84103
  • Salt Lake City, UT
  • 909 58Th St, Indianapolis, IN 46220 (317) 205-9140
  • Pittsburgh, PA
  • Cornelius, NC
  • Carbondale, IL
  • Elmsford, NY

Work

Position: Professional/Technical

Education

Degree: Associate degree or higher

Emails

Resumes

Resumes

Michael Statnick Photo 1

Director Of Disease Biology

View page
Location:
108 U St, Salt Lake City, UT 84103
Industry:
Pharmaceuticals
Work:
Epiodyne Jan 2018 - Dec 2018
Consultant

Mas Scientific Solutions Dec 2017 - Dec 2018
President and Chief Executive Officer

Recursion Pharmaceuticals Dec 2017 - Dec 2018
Director of Disease Biology

Eli Lilly and Company Oct 2010 - Dec 2017
Senior Research Advisor

Eli Lilly and Company Jan 1998 - Oct 2010
Research Advisor
Education:
Southern Illinois University, Carbondale 1988 - 1994
Doctorates, Doctor of Philosophy, Physiology
Slippery Rock University of Pennsylvania 1984 - 1988
Bachelors, Bachelor of Science, Biology
Skills:
Drug Discovery
Neuroscience
Clinical Development
Pharmaceutical Industry
Gpcrs
Lead Change
In Vivo
Drug Development
Pharmacology
In Vitro
Assay Development
Diabetes
Biomarkers
Target Identification
Protein Chemistry
Clinical Trials
Biomarker Discovery
Endocrinology
Adme
Medicinal Chemistry
Biopharmaceuticals
Pharmacokinetics
Ind
Cro
Translational Medicine
Toxicology
Drug Metabolism
Metabolic Syndrome
Molecular Pharmacology
Drug Design
High Throughput Screening
Metabolism
Laboratory
Obesity
Islet Biology
Mood Disorders
Addictions
Binge Eating Disorder
Alcohol Dependence
Michael Statnick Photo 2

Michael Statnick

View page
Location:
Indianapolis, IN
Michael Statnick Photo 3

Michael Statnick

View page

Publications

Us Patents

Diaryl Ethers As Opioid Receptor Antagonists

View page
US Patent:
7560463, Jul 14, 2009
Filed:
Mar 21, 2008
Appl. No.:
12/052994
Inventors:
Charles Howard Mitch - Columbus IN, US
Michael Angelo Statnick - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/4965
US Classification:
51425505
Abstract:
Compound 5-(2-Methoxy-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-pyrazine-2-carboxamide or a pharmaceutically acceptable salt thereof, useful for the treatment of irritable bowel syndrome.
Michael A Statnick from Salt Lake City, UT, age ~58 Get Report